scispace - formally typeset
A

Alexis N. LaCrue

Researcher at University of South Florida

Publications -  19
Citations -  598

Alexis N. LaCrue is an academic researcher from University of South Florida. The author has contributed to research in topics: Plasmodium falciparum & Plasmodium berghei. The author has an hindex of 10, co-authored 18 publications receiving 537 citations. Previous affiliations of Alexis N. LaCrue include University of Missouri.

Papers
More filters
Journal ArticleDOI

Quinolone-3-Diarylethers: A New Class of Antimalarial Drug

TL;DR: ELQ-300, a 4(1H)-quinolone-3-diarylether, which targets the liver and blood stages, including the forms that are crucial to disease transmission (gametocytes, zygotes, and ookinetes), has potential as a new drug for the treatment, prevention, and, ultimately, eradication of human malaria.
Journal ArticleDOI

Effects of Artesunate on Parasite Recrudescence and Dormancy in the Rodent Malaria Model Plasmodium vinckei

TL;DR: Data suggest that dormancy occurs in vivo and contributes to recrudescence that is observed following AS treatment, and there is a positive correlation between the number of dormant parasites present and when recrUDescence occurs in the vertebrate host.
Journal ArticleDOI

Fatty Acid Synthesis and Pyruvate Metabolism Pathways Remain Active in Dihydroartemisinin-Induced Dormant Ring Stages of Plasmodium falciparum

TL;DR: Investigation of transcription of 12 genes encoding key enzymes in various metabolic pathways in P. falciparum during dihydroartemisinin (DHA)-induced dormancy and recovery demonstrates that most metabolic pathways are downregulated in DHA-induced dormant parasites.
Journal ArticleDOI

4(1H)-Quinolones with Liver Stage Activity against Plasmodium berghei

TL;DR: Results showed that all of the compounds were active against liver stage parasites; however, ICI 56,780 and P4Q-158 were the most active, with low nanomolar activity in vitro and causal prophylactic activity in vivo.